ID   DPYL2_HUMAN             Reviewed;         572 AA.
AC   Q16555; A8K5H2; B4DR31; D3DSS7; O00424;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   10-MAY-2017, entry version 176.
DE   RecName: Full=Dihydropyrimidinase-related protein 2;
DE            Short=DRP-2;
DE   AltName: Full=Collapsin response mediator protein 2;
DE            Short=CRMP-2;
DE   AltName: Full=N2A3;
DE   AltName: Full=Unc-33-like phosphoprotein 2;
DE            Short=ULIP-2;
GN   Name=DPYSL2; Synonyms=CRMP2, ULIP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7637782; DOI=10.1038/376509a0;
RA   Goshima Y., Nakamura F., Strittmatter P., Strittmatter S.M.;
RT   "Collapsin-induced growth cone collapse mediated by an intracellular
RT   protein related to UNC-33.";
RL   Nature 376:509-514(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8973361; DOI=10.1016/S0378-1119(96)00445-3;
RA   Hamajima N., Matsuda K., Sakata S., Tamaki N., Sasaki M., Nonaka M.;
RT   "A novel gene family defined by human dihydropyrimidinase and three
RT   related proteins with differential tissue distribution.";
RL   Gene 180:157-163(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal liver;
RA   Zhou J., Chen Y., Gu J.R.;
RT   "A cDNA clone highly expressed in human brain and deleted in liver
RT   cancer.";
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10574455; DOI=10.1093/dnares/6.5.291;
RA   Kitamura K., Takayama M., Hamajima N., Nakanishi M., Sasaki M.,
RA   Endo Y., Takemoto T., Kimura H., Iwaki M., Nonaka M.;
RT   "Characterization of the human dihydropyrimidinase-related protein 2
RT   (DRP-2) gene.";
RL   DNA Res. 6:291-297(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 44-56; 64-75; 147-157; 174-211; 239-254; 375-390;
RP   401-418; 424-467; 497-511 AND 533-552, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   PHOSPHORYLATION AT SER-518; SER-522 AND THR-509, AND MUTAGENESIS OF
RP   SER-507; THR-509; THR-512; THR-514; SER-517; SER-518; THR-521 AND
RP   SER-522.
RX   PubMed=10757975; DOI=10.1021/bi992323h;
RA   Gu Y., Hamajima N., Ihara Y.;
RT   "Neurofibrillary tangle-associated collapsin response mediator
RT   protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, and
RT   Ser-522.";
RL   Biochemistry 39:4267-4275(2000).
RN   [11]
RP   FUNCTION.
RX   PubMed=11477421; DOI=10.1038/90476;
RA   Inagaki N., Chihara K., Arimura N., Menager C., Kawano Y., Matsuo N.,
RA   Nishimura T., Amano M., Kaibuchi K.;
RT   "CRMP-2 induces axons in cultured hippocampal neurons.";
RL   Nat. Neurosci. 4:781-782(2001).
RN   [12]
RP   FUNCTION, AND PHOSPHORYLATION AT SER-522.
RX   PubMed=15466863; DOI=10.1074/jbc.C400412200;
RA   Cole A.R., Knebel A., Morrice N.A., Robertson L.A., Irving A.J.,
RA   Connolly C.N., Sutherland C.;
RT   "GSK-3 phosphorylation of the Alzheimer epitope within collapsin
RT   response mediator proteins regulates axon elongation in primary
RT   neurons.";
RL   J. Biol. Chem. 279:50176-50180(2004).
RN   [13]
RP   INTERACTION WITH CYFIP1, AND MUTAGENESIS OF ASP-71.
RX   PubMed=16260607; DOI=10.1128/MCB.25.22.9920-9935.2005;
RA   Kawano Y., Yoshimura T., Tsuboi D., Kawabata S., Kaneko-Kawano T.,
RA   Shirataki H., Takenawa T., Kaibuchi K.;
RT   "CRMP-2 is involved in kinesin-1-dependent transport of the Sra-
RT   1/WAVE1 complex and axon formation.";
RL   Mol. Cell. Biol. 25:9920-9935(2005).
RN   [14]
RP   INTERACTION WITH PLEXNA1, AND SUBUNIT.
RX   PubMed=14685275; DOI=10.1038/sj.emboj.7600021;
RA   Deo R.C., Schmidt E.F., Elhabazi A., Togashi H., Burley S.K.,
RA   Strittmatter S.M.;
RT   "Structural bases for CRMP function in plexin-dependent semaphorin3A
RT   signaling.";
RL   EMBO J. 23:9-22(2004).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-509 AND SER-522, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-509, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   PHOSPHORYLATION AT TYR-32 BY FYN.
RX   PubMed=19652227; DOI=10.1074/jbc.M109.000240;
RA   Uchida Y., Ohshima T., Yamashita N., Ogawara M., Sasaki Y.,
RA   Nakamura F., Goshima Y.;
RT   "Semaphorin3A signaling mediated by Fyn-dependent tyrosine
RT   phosphorylation of collapsin response mediator protein 2 at tyrosine
RT   32.";
RL   J. Biol. Chem. 284:27393-27401(2009).
RN   [19]
RP   INTERACTION WITH CLN6.
RX   PubMed=19235893; DOI=10.1002/jnr.22032;
RA   Benedict J.W., Getty A.L., Wishart T.M., Gillingwater T.H.,
RA   Pearce D.A.;
RT   "Protein product of CLN6 gene responsible for variant late-onset
RT   infantile neuronal ceroid lipofuscinosis interacts with CRMP-2.";
RL   J. Neurosci. Res. 87:2157-2166(2009).
RN   [20]
RP   FUNCTION IN ENDOCYTOSIS, INTERACTION WITH MICALL1, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=20801876; DOI=10.1074/jbc.C110.166066;
RA   Rahajeng J., Giridharan S.S., Naslavsky N., Caplan S.;
RT   "Collapsin response mediator protein-2 (Crmp2) regulates trafficking
RT   by linking endocytic regulatory proteins to dynein motors.";
RL   J. Biol. Chem. 285:31918-31922(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-509; THR-514; SER-517;
RP   SER-518 AND SER-522, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-509, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 12-490, AND SUBUNIT.
RX   PubMed=17250651; DOI=10.1111/j.1471-4159.2006.04401.x;
RA   Stenmark P., Ogg D., Flodin S., Flores A., Kotenyova T., Nyman T.,
RA   Nordlund P., Kursula P.;
RT   "The structure of human collapsin response mediator protein 2, a
RT   regulator of axonal growth.";
RL   J. Neurochem. 101:906-917(2007).
RN   [29]
RP   VARIANT [LARGE SCALE ANALYSIS] CYS-481.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Plays a role in neuronal development and polarity, as
CC       well as in axon growth and guidance, neuronal growth cone collapse
CC       and cell migration. Necessary for signaling by class 3 semaphorins
CC       and subsequent remodeling of the cytoskeleton. May play a role in
CC       endocytosis. {ECO:0000269|PubMed:11477421,
CC       ECO:0000269|PubMed:15466863, ECO:0000269|PubMed:20801876}.
CC   -!- SUBUNIT: Homotetramer, and heterotetramer with CRMP1, DPYSL3,
CC       DPYSL4 or DPYSL5. Interacts through its C-terminus with the C-
CC       terminus of CYFIP1/SRA1. Interacts with HTR4. Interacts with CLN6.
CC       Interacts with MICALL1. {ECO:0000269|PubMed:14685275,
CC       ECO:0000269|PubMed:16260607, ECO:0000269|PubMed:17250651,
CC       ECO:0000269|PubMed:19235893, ECO:0000269|PubMed:20801876}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-1104711, EBI-1104711;
CC       Q14194:CRMP1; NbExp=3; IntAct=EBI-1104711, EBI-473101;
CC       Q14195-2:DPYSL3; NbExp=7; IntAct=EBI-1104711, EBI-10232496;
CC       Q8IXW6:DPYSL3; NbExp=3; IntAct=EBI-1104711, EBI-10262612;
CC       Q9BPU6:DPYSL5; NbExp=9; IntAct=EBI-1104711, EBI-724653;
CC       Q9H8Y8:GORASP2; NbExp=7; IntAct=EBI-1104711, EBI-739467;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:20801876}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:20801876}. Membrane
CC       {ECO:0000269|PubMed:20801876}. Note=Tightly but non-covalently
CC       associated with membranes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q16555-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16555-2; Sequence=VSP_044941;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: 3F4, a monoclonal antibody which strongly stains
CC       neurofibrillary tangles in Alzheimer disease brains, specifically
CC       labels DPYSL2 when phosphorylated on Ser-518, Ser-522 and Thr-509.
CC       {ECO:0000269|PubMed:10757975, ECO:0000269|PubMed:15466863}.
CC   -!- PTM: Phosphorylation at Thr-514 by GSK3B abolishes tubulin-binding
CC       leading to destabilization of microtubule assembly in axons and
CC       neurodegeneration (By similarity). Phosphorylation by DYRK2 at
CC       Ser-522 is required for subsequent phosphorylation by GSK3B.
CC       {ECO:0000250, ECO:0000269|PubMed:10757975,
CC       ECO:0000269|PubMed:15466863}.
CC   -!- SIMILARITY: Belongs to the DHOase family.
CC       Hydantoinase/dihydropyrimidinase subfamily. {ECO:0000305}.
CC   -!- CAUTION: Lacks most of the conserved residues that are essential
CC       for binding the metal cofactor and hence for dihydropyrimidinase
CC       activity. Its enzyme activity is therefore unsure. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U17279; AAA93202.1; -; mRNA.
DR   EMBL; D78013; BAA11191.1; -; mRNA.
DR   EMBL; U97105; AAC05793.1; -; mRNA.
DR   EMBL; AB020777; BAA86991.1; -; Genomic_DNA.
DR   EMBL; AK291287; BAF83976.1; -; mRNA.
DR   EMBL; AK299077; BAG61143.1; -; mRNA.
DR   EMBL; AC015564; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC015743; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471080; EAW63573.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63574.1; -; Genomic_DNA.
DR   EMBL; BC056408; AAH56408.1; -; mRNA.
DR   EMBL; BC067109; AAH67109.1; -; mRNA.
DR   CCDS; CCDS59096.1; -. [Q16555-2]
DR   CCDS; CCDS6051.1; -. [Q16555-1]
DR   PIR; JC5317; JC5317.
DR   RefSeq; NP_001184222.1; NM_001197293.2.
DR   RefSeq; NP_001231533.1; NM_001244604.1. [Q16555-2]
DR   RefSeq; NP_001377.1; NM_001386.5. [Q16555-1]
DR   UniGene; Hs.593187; -.
DR   PDB; 2GSE; X-ray; 2.40 A; A/B/C/D=13-490.
DR   PDB; 2VM8; X-ray; 1.90 A; A/B/C/D=13-490.
DR   PDB; 5LXX; X-ray; 1.25 A; A/B=13-490.
DR   PDB; 5MKV; X-ray; 1.80 A; A/B/C/D=13-516.
DR   PDB; 5MLE; X-ray; 2.48 A; A/C=13-516.
DR   PDBsum; 2GSE; -.
DR   PDBsum; 2VM8; -.
DR   PDBsum; 5LXX; -.
DR   PDBsum; 5MKV; -.
DR   PDBsum; 5MLE; -.
DR   ProteinModelPortal; Q16555; -.
DR   SMR; Q16555; -.
DR   BioGrid; 108142; 54.
DR   IntAct; Q16555; 19.
DR   MINT; MINT-3032752; -.
DR   STRING; 9606.ENSP00000309539; -.
DR   MEROPS; M38.975; -.
DR   iPTMnet; Q16555; -.
DR   PhosphoSitePlus; Q16555; -.
DR   SwissPalm; Q16555; -.
DR   BioMuta; DPYSL2; -.
DR   DMDM; 3122051; -.
DR   REPRODUCTION-2DPAGE; IPI00257508; -.
DR   REPRODUCTION-2DPAGE; Q16555; -.
DR   UCD-2DPAGE; Q16555; -.
DR   EPD; Q16555; -.
DR   MaxQB; Q16555; -.
DR   PaxDb; Q16555; -.
DR   PeptideAtlas; Q16555; -.
DR   PRIDE; Q16555; -.
DR   TopDownProteomics; Q16555-1; -. [Q16555-1]
DR   Ensembl; ENST00000311151; ENSP00000309539; ENSG00000092964. [Q16555-1]
DR   Ensembl; ENST00000523027; ENSP00000431117; ENSG00000092964. [Q16555-2]
DR   GeneID; 1808; -.
DR   KEGG; hsa:1808; -.
DR   UCSC; uc003xfb.3; human. [Q16555-1]
DR   CTD; 1808; -.
DR   DisGeNET; 1808; -.
DR   GeneCards; DPYSL2; -.
DR   HGNC; HGNC:3014; DPYSL2.
DR   HPA; CAB018719; -.
DR   HPA; HPA002381; -.
DR   MIM; 602463; gene.
DR   neXtProt; NX_Q16555; -.
DR   OpenTargets; ENSG00000092964; -.
DR   PharmGKB; PA27472; -.
DR   eggNOG; KOG2584; Eukaryota.
DR   eggNOG; COG0044; LUCA.
DR   GeneTree; ENSGT00760000119241; -.
DR   HOGENOM; HOG000219145; -.
DR   HOVERGEN; HBG000806; -.
DR   InParanoid; Q16555; -.
DR   KO; K07528; -.
DR   OMA; QQRDVAH; -.
DR   OrthoDB; EOG091G05F3; -.
DR   PhylomeDB; Q16555; -.
DR   TreeFam; TF314706; -.
DR   Reactome; R-HSA-399956; CRMPs in Sema3A signaling.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   SIGNOR; Q16555; -.
DR   ChiTaRS; DPYSL2; human.
DR   EvolutionaryTrace; Q16555; -.
DR   GeneWiki; DPYSL2; -.
DR   GenomeRNAi; 1808; -.
DR   PRO; PR:Q16555; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000092964; -.
DR   CleanEx; HS_DPYSL2; -.
DR   ExpressionAtlas; Q16555; baseline and differential.
DR   Genevisible; Q16555; HS.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0004157; F:dihydropyrimidinase activity; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008017; F:microtubule binding; IEA:InterPro.
DR   GO; GO:0007411; P:axon guidance; IEA:InterPro.
DR   GO; GO:0007420; P:brain development; IEA:InterPro.
DR   GO; GO:0007010; P:cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; IMP:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0030516; P:regulation of axon extension; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd01314; D-HYD; 1.
DR   Gene3D; 2.30.40.10; -; 1.
DR   InterPro; IPR006680; Amidohydro-rel.
DR   InterPro; IPR030615; DRP2.
DR   InterPro; IPR011778; Hydantoinase/dihydroPyrase.
DR   InterPro; IPR011059; Metal-dep_hydrolase_composite.
DR   InterPro; IPR032466; Metal_Hydrolase.
DR   PANTHER; PTHR11647:SF87; PTHR11647:SF87; 1.
DR   Pfam; PF01979; Amidohydro_1; 1.
DR   SUPFAM; SSF51338; SSF51338; 2.
DR   SUPFAM; SSF51556; SSF51556; 1.
DR   TIGRFAMs; TIGR02033; D-hydantoinase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Developmental protein; Differentiation;
KW   Direct protein sequencing; Membrane; Methylation; Neurogenesis;
KW   Phosphoprotein; Polymorphism; Reference proteome; S-nitrosylation.
FT   CHAIN         1    572       Dihydropyrimidinase-related protein 2.
FT                                /FTId=PRO_0000165913.
FT   MOD_RES      32     32       Phosphotyrosine; by FYN.
FT                                {ECO:0000269|PubMed:19652227}.
FT   MOD_RES     101    101       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q14194}.
FT   MOD_RES     102    102       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q14194}.
FT   MOD_RES     258    258       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     259    259       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P47942}.
FT   MOD_RES     431    431       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     465    465       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     499    499       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     504    504       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:P47942}.
FT   MOD_RES     507    507       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     509    509       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:10757975}.
FT   MOD_RES     512    512       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     514    514       Phosphothreonine; by GSK3-beta.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     517    517       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     518    518       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:10757975}.
FT   MOD_RES     521    521       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     522    522       Phosphoserine; by DYRK2.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:10757975,
FT                                ECO:0000269|PubMed:15466863}.
FT   MOD_RES     537    537       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     540    540       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     542    542       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     555    555       Phosphothreonine; by ROCK2.
FT                                {ECO:0000250}.
FT   MOD_RES     565    565       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   VAR_SEQ       1     36       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044941.
FT   VARIANT     118    118       A -> T (in dbSNP:rs2289593).
FT                                /FTId=VAR_022016.
FT   VARIANT     481    481       R -> C (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036316.
FT   MUTAGEN      71     71       D->N: Inhibits axon outgrowth formation
FT                                in hippocampal neurons and decreases
FT                                binding to CYFIP1.
FT                                {ECO:0000269|PubMed:16260607}.
FT   MUTAGEN     507    507       S->A: No effect.
FT                                {ECO:0000269|PubMed:10757975}.
FT   MUTAGEN     509    509       T->A: Greatly diminishes binding to 3F4
FT                                antibody. {ECO:0000269|PubMed:10757975}.
FT   MUTAGEN     512    512       T->A: No effect.
FT                                {ECO:0000269|PubMed:10757975}.
FT   MUTAGEN     514    514       T->A: No effect.
FT                                {ECO:0000269|PubMed:10757975}.
FT   MUTAGEN     517    517       S->A: No effect.
FT                                {ECO:0000269|PubMed:10757975}.
FT   MUTAGEN     518    518       S->A: Greatly diminishes binding to 3F4
FT                                antibody. {ECO:0000269|PubMed:10757975}.
FT   MUTAGEN     521    521       T->A: No effect.
FT                                {ECO:0000269|PubMed:10757975}.
FT   MUTAGEN     522    522       S->A: Greatly diminishes binding to 3F4
FT                                antibody. {ECO:0000269|PubMed:10757975}.
FT   STRAND       17     21       {ECO:0000244|PDB:5LXX}.
FT   STRAND       23     25       {ECO:0000244|PDB:5LXX}.
FT   STRAND       30     32       {ECO:0000244|PDB:5LXX}.
FT   STRAND       34     38       {ECO:0000244|PDB:5LXX}.
FT   STRAND       41     48       {ECO:0000244|PDB:5LXX}.
FT   STRAND       53     55       {ECO:0000244|PDB:2VM8}.
FT   STRAND       56     59       {ECO:0000244|PDB:5LXX}.
FT   STRAND       64     67       {ECO:0000244|PDB:5LXX}.
FT   STRAND       69     72       {ECO:0000244|PDB:5LXX}.
FT   HELIX        89     98       {ECO:0000244|PDB:5LXX}.
FT   STRAND      101    108       {ECO:0000244|PDB:5LXX}.
FT   HELIX       116    130       {ECO:0000244|PDB:5LXX}.
FT   STRAND      132    140       {ECO:0000244|PDB:5LXX}.
FT   HELIX       148    159       {ECO:0000244|PDB:5LXX}.
FT   STRAND      163    168       {ECO:0000244|PDB:5LXX}.
FT   TURN        171    173       {ECO:0000244|PDB:5LXX}.
FT   HELIX       178    191       {ECO:0000244|PDB:5LXX}.
FT   STRAND      194    198       {ECO:0000244|PDB:5LXX}.
FT   HELIX       202    214       {ECO:0000244|PDB:5LXX}.
FT   HELIX       220    226       {ECO:0000244|PDB:5LXX}.
FT   HELIX       229    246       {ECO:0000244|PDB:5LXX}.
FT   STRAND      250    255       {ECO:0000244|PDB:5LXX}.
FT   HELIX       258    269       {ECO:0000244|PDB:5LXX}.
FT   STRAND      274    279       {ECO:0000244|PDB:5LXX}.
FT   HELIX       280    284       {ECO:0000244|PDB:5LXX}.
FT   HELIX       287    291       {ECO:0000244|PDB:5LXX}.
FT   HELIX       295    300       {ECO:0000244|PDB:5LXX}.
FT   HELIX       313    322       {ECO:0000244|PDB:5LXX}.
FT   HELIX       338    341       {ECO:0000244|PDB:5LXX}.
FT   HELIX       342    344       {ECO:0000244|PDB:5LXX}.
FT   HELIX       348    350       {ECO:0000244|PDB:5LXX}.
FT   TURN        358    360       {ECO:0000244|PDB:5LXX}.
FT   HELIX       361    369       {ECO:0000244|PDB:5LXX}.
FT   TURN        370    373       {ECO:0000244|PDB:5LXX}.
FT   HELIX       377    384       {ECO:0000244|PDB:5LXX}.
FT   HELIX       386    391       {ECO:0000244|PDB:5LXX}.
FT   TURN        395    397       {ECO:0000244|PDB:5LXX}.
FT   STRAND      409    419       {ECO:0000244|PDB:5LXX}.
FT   TURN        422    424       {ECO:0000244|PDB:5LXX}.
FT   STRAND      425    428       {ECO:0000244|PDB:5LXX}.
FT   TURN        433    436       {ECO:0000244|PDB:5LXX}.
FT   STRAND      438    448       {ECO:0000244|PDB:5LXX}.
FT   STRAND      451    455       {ECO:0000244|PDB:5LXX}.
FT   HELIX       476    486       {ECO:0000244|PDB:5LXX}.
SQ   SEQUENCE   572 AA;  62294 MW;  5CDB6CF7F5C308AD CRC64;
     MSYQGKKNIP RITSDRLLIK GGKIVNDDQS FYADIYMEDG LIKQIGENLI VPGGVKTIEA
     HSRMVIPGGI DVHTRFQMPD QGMTSADDFF QGTKAALAGG TTMIIDHVVP EPGTSLLAAF
     DQWREWADSK SCCDYSLHVD ISEWHKGIQE EMEALVKDHG VNSFLVYMAF KDRFQLTDCQ
     IYEVLSVIRD IGAIAQVHAE NGDIIAEEQQ RILDLGITGP EGHVLSRPEE VEAEAVNRAI
     TIANQTNCPL YITKVMSKSS AEVIAQARKK GTVVYGEPIT ASLGTDGSHY WSKNWAKAAA
     FVTSPPLSPD PTTPDFLNSL LSCGDLQVTG SAHCTFNTAQ KAVGKDNFTL IPEGTNGTEE
     RMSVIWDKAV VTGKMDENQF VAVTSTNAAK VFNLYPRKGR IAVGSDADLV IWDPDSVKTI
     SAKTHNSSLE YNIFEGMECR GSPLVVISQG KIVLEDGTLH VTEGSGRYIP RKPFPDFVYK
     RIKARSRLAE LRGVPRGLYD GPVCEVSVTP KTVTPASSAK TSPAKQQAPP VRNLHQSGFS
     LSGAQIDDNI PRRTTQRIVA PPGGRANITS LG
//
